Nothing Special   »   [go: up one dir, main page]

JPS625917B2 - - Google Patents

Info

Publication number
JPS625917B2
JPS625917B2 JP50074251A JP7425175A JPS625917B2 JP S625917 B2 JPS625917 B2 JP S625917B2 JP 50074251 A JP50074251 A JP 50074251A JP 7425175 A JP7425175 A JP 7425175A JP S625917 B2 JPS625917 B2 JP S625917B2
Authority
JP
Japan
Prior art keywords
group
methyl
dioxo
ethyl
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50074251A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5113793A (de
Inventor
Montafuon Maruku
Rainaa Rooran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5113793A publication Critical patent/JPS5113793A/ja
Publication of JPS625917B2 publication Critical patent/JPS625917B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50074251A 1974-06-21 1975-06-18 Expired JPS625917B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (2)

Publication Number Publication Date
JPS5113793A JPS5113793A (de) 1976-02-03
JPS625917B2 true JPS625917B2 (de) 1987-02-07

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50074251A Expired JPS625917B2 (de) 1974-06-21 1975-06-18

Country Status (25)

Country Link
JP (1) JPS625917B2 (de)
AT (1) AT337897B (de)
AU (1) AU498387B2 (de)
BE (1) BE830455A (de)
BR (1) BR7503782A (de)
CA (1) CA1111021A (de)
CH (1) CH609989A5 (de)
CU (1) CU34293A (de)
DD (1) DD121113A5 (de)
DE (1) DE2527291A1 (de)
DK (2) DK153155C (de)
FI (1) FI751815A (de)
FR (1) FR2275215A1 (de)
GB (1) GB1471804A (de)
HU (1) HU170576B (de)
IE (1) IE41888B1 (de)
IL (1) IL47299A (de)
LU (1) LU72771A1 (de)
NL (1) NL180665C (de)
NO (1) NO752202L (de)
NZ (1) NZ177508A (de)
PH (1) PH13030A (de)
SE (1) SE431755B (de)
SU (2) SU635873A3 (de)
ZA (1) ZA753086B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
WO2002086143A2 (en) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Enzymatic process for preparing cephalosporin derivatives
AU2009221328B2 (en) 2008-03-05 2014-02-27 Merck Patent Gmbh Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
DK271975A (da) 1975-12-22
FR2275215A1 (fr) 1976-01-16
CH609989A5 (en) 1979-03-30
FR2275215B1 (de) 1980-05-16
LU72771A1 (de) 1977-03-04
DE2527291A1 (de) 1976-01-08
DK153155B (da) 1988-06-20
CA1111021A (en) 1981-10-20
AT337897B (de) 1977-07-25
NL180665B (nl) 1986-11-03
DK153155C (da) 1988-10-31
BR7503782A (pt) 1976-07-06
NO752202L (de) 1975-12-23
ATA476975A (de) 1976-11-15
DK155329C (da) 1989-08-07
HU170576B (de) 1977-07-28
IL47299A0 (en) 1976-10-31
SU635873A3 (ru) 1978-11-30
ZA753086B (en) 1976-04-28
PH13030A (en) 1979-11-15
DE2527291C2 (de) 1988-01-14
NL180665C (nl) 1987-04-01
IE41888B1 (en) 1980-04-23
AU8191275A (en) 1976-12-09
DK453687A (da) 1987-08-28
GB1471804A (en) 1977-04-27
DK453687D0 (da) 1987-08-28
DD121113A5 (de) 1976-07-12
SE7506908L (sv) 1975-12-22
SU589921A3 (ru) 1978-01-25
DK155329B (da) 1989-03-28
FI751815A (de) 1975-12-22
NZ177508A (en) 1978-04-03
AU498387B2 (en) 1979-03-08
CU34293A (es) 1979-01-16
BE830455A (fr) 1975-12-22
JPS5113793A (de) 1976-02-03
NL7507390A (nl) 1975-12-23
IL47299A (en) 1979-01-31
SE431755B (sv) 1984-02-27
IE41888L (en) 1975-12-21

Similar Documents

Publication Publication Date Title
EP0189287B1 (de) Beta-Lactam-Antibiotika
US3984403A (en) Arginine and lysine salts of acid cephalosporins
US4603129A (en) Cephalosporin derivatives
JPS5858353B2 (ja) セフエムまたはペナム化合物およびその製造法
JPH0710870B2 (ja) 新規セフェム化合物
JPH0333712B2 (de)
KR910000035B1 (ko) 세팔로스포린 화합물, 이의 제법 및 이를 함유하는 약학적 조성물
EP0112164A2 (de) Cephemverbindungen, ihre Herstellung und sie enthaltende Medikamente
JPS625917B2 (de)
US4091211A (en) Cephalosporins
IE41590B1 (en) Novel cephalosporin compounds
JPH0633281B2 (ja) 新規セファロスポリン化合物及び抗菌剤
US4348518A (en) Cephalosporins
JP2529093B2 (ja) セファロスポリン中間体の製造方法
KR790001023B1 (ko) 아실 유도체의 제조방법
US4239758A (en) Cephalosporins
KR870000611B1 (ko) 세팔로스포린의 제조방법
JPH0723381B2 (ja) 新規セフアロスポリン誘導体及び抗菌剤
US4111981A (en) Intermediates for preparing substituted phenylglycylcephalosporins
JPH09506100A (ja) 抗炎症剤および抗変性剤としての2−スピロ(2’−スピロシクロアルキル)シクロプロピルセファロスポリンスルホン類
JPH0613529B2 (ja) 新規セフアロスポリン誘導体及び抗菌剤
US4003893A (en) 3-Heterothio[(thioalkyl)thioacetyl]cephalosporanic derivatives
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
JP2787683B2 (ja) 新規なペナム誘導体およびその塩
US4022895A (en) Substituted phenylglycylcephalosporins